- Abstract:
-
BACKGROUND: Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. OBJECTIVE: To determine outcomes for men diagnosed with advanced PCa following prostate-specific antigen (PSA) testing who were excluded from the ProtecT randomised trial. DESIGN, SETTING, AND PARTICIPANTS: Mortality was compared for 492 men followed up for a median of 7.4 yr to a contemporaneous cohort of men from the UK Anglia Cancer Network (ACN) and w...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Publisher:
- Elsevier Publisher's website
- Journal:
- European Urology Journal website
- Volume:
- 71
- Issue:
- 3
- Pages:
- 381-388
- Publication date:
- 2016-10-06
- Acceptance date:
- 2016-09-26
- DOI:
- EISSN:
-
1873-7560
- ISSN:
-
0302-2838
- Pubs id:
-
pubs:653521
- URN:
-
uri:feb2cc6f-86e4-4af1-b7c1-a28815ccfae1
- UUID:
-
uuid:feb2cc6f-86e4-4af1-b7c1-a28815ccfae1
- Local pid:
- pubs:653521
- Paper number:
- 3
- Language:
- English
- Keywords:
- Copyright holder:
- European Association of Urology
- Copyright date:
- 2016
- Notes:
-
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Journal article
Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
Actions
Authors
Funding
Cancer Research UK
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record